Biomarkers, nerve cells and genes
Laboratory research aims to clarify the causes of MS. Biosamples and MRI images which are collected in cohort studies and by other means are used to examine genes, cells and brain structures. For example, researchers strive to identify biomarkers in order to find factors which contribute to the cause and progression of the disease and also to be able to predict which patient will respond to which medication.
In the consortium „Prognostic and treatment markers“, researchers are working to define immunological and imaging characteristics which serve as markers for prognosis, treatment success and treatment risks.
In the consortium „Determinants of MS phenotypes“, genetic variants will be identified and validated which influence single MRI parameters and CSF characteristics connected to MS and NMO.
In the consortium „Models“, investigators work to develop new MS disease models to help improve the pre-clinical research possibilities.